<!--Introduction---------------------------------------------->  
        <TABLE WIDTH="100%" BGCOLOR="#888888" BORDER="0" CELLSPACING="0" CELLPADDING="1">
            <TR><TD>        
            <TABLE BGCOLOR="#fffee8" WIDTH="100%"  BORDER="0" CELLSPACING="0" CELLPADDING="0">
                <TR><TD>        
                <TABLE BGCOLOR="#D9E4F8" BACKGROUND="../../images/hr.gif" WIDTH="100%"><TR><TD>
                    <A NAME="About"></A><FONT SIZE="4"><B>
&nbsp;
EmArray Cyto6000 - Oligonucleotide Array Analysis with FISH Confirmation
<BR>&nbsp;
CLINICAL INTERPRETATION AND SIGNIFICANCE
</B></FONT>

                </TD></TR></TABLE>
        
                <TABLE BGCOLOR="#fffee8" WIDTH="100%" CELLPADDING=0>
                    <TR><TH HEIGHT=3></TH></TR>
                    <TR><TD WIDTH=10></TD><TD>
                    <P> &nbsp;

<BR>
<B>Results</B>: ABNORMAL FEMALE MICROARRAY ANALYSIS
</P>
<P> 
NOMENCLATURE:  arr cgh <B>22</B>q11.21(<B>17,086,001</B>bp-><B>19,835,417</B>bp)x1

</P>
<P>
Microarray and confirmatory Fluorescence In Situ Hybridization 
(FISH) analyses revealed an interstitial deletion of the long 
arm of chromosome 22 involving the <B>22q11.2</B> deletion syndrome 
region. The 22q11.2 deletion syndrome is also known as 
<B>Velocardiofacial</B> syndrome and <B>DiGeorge</B> syndrome (OMIM #<B>192430</B>) 
and is characterized by features such as developmental delays, 
particularly in the areas of speech/language, craniofacial 
anomalies, such as cleft palate, congenital heart defects, 
hypocalcemia and immune deficiency. The deletion in this 
individual is 2.75 Megabases (Mb) in size, consistent with 
the common 3.0 Mb deletion of the 22q11.2 Deletion syndrome 
region.

</P>
<P>

Thanks to Christa Martin, Emory University, for providing the original
document.
</P>
<P>
        	    

		    </P>
                    </TD><TD WIDTH=15>
                </TD></TR></TABLE>
            <BR></TD></TR></TABLE>
        </TD></TR></TABLE>
